Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns

Ahroni, 2000, Responsiveness of the SF-36 among veterans with diabetes mellitus, Journal of Diabetes and its Complications, 14, 31, 10.1016/S1056-8727(00)00066-0 American Diabetes Association, 1998, Economic consequences of diabetes mellitus in the U.S. in 1997, Diabetes Care, 21, 296, 10.2337/diacare.21.2.296 Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial, Journal of the American Medical Association, 280, 1831, 10.1001/jama.280.21.1831 Backonja, 2003, Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials, Clinical Therapeutics, 25, 81, 10.1016/S0149-2918(03)90011-7 Benbow, 1998, Diabetic peripheral neuropathy and quality of life, Quarterly Journal of Medicine, 91, 733, 10.1093/qjmed/91.11.733 Brandle, 2003, The direct costs of type 2 diabetes, Diabetes Care, 26, 2300, 10.2337/diacare.26.8.2300 Brooks, 1996, EuroQol: The current state of play, Health Policy, 37, 53, 10.1016/0168-8510(96)00822-6 Cleeland, 1994, Pain assessment: Global use of the Brief Pain Inventory, Annals of the Academy of Medicine, Singapore, 23, 129 Coffey, 2002, Valuing health-related quality of life in diabetes, Diabetes Care, 25, 2238, 10.2337/diacare.25.12.2238 Daousi, 2004, Chronic painful peripheral neuropathy in an urban community: A controlled comparison of people with and without diabetes, Diabetic Medicine, 21, 976, 10.1111/j.1464-5491.2004.01271.x Daut, 1983, Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases, Pain, 17, 197, 10.1016/0304-3959(83)90143-4 de Groot, 2001, Association of depression and diabetes complications: A meta-analysis, Psychosomatic Medicine, 63, 619, 10.1097/00006842-200107000-00015 Dolan, 1997, Modeling valuations for EuroQol health states, Medical Care, 35, 1095, 10.1097/00005650-199711000-00002 Dworkin, 2003, Advances in neuropathic pain. Diagnosis, mechanisms, and treatment recommendations, Archives of Neurology, 60 Galer, 2000, Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life, Diabetes Research and Clinical Practice, 47, 123, 10.1016/S0168-8227(99)00112-6 Galer, 1997, Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale, Neurology, 48, 332, 10.1212/WNL.48.2.332 Gambaro, 2003, Adverse renal effects of anti-inflammatory agents: Evaluation of selective and nonselective cyclooxygenase inhibitors, Journal of Internal Medicine, 253, 643, 10.1046/j.1365-2796.2003.01146.x Gordois, 2003, The health care costs of diabetic peripheral neuropathy in the U.S., Diabetes Care, 26, 1790, 10.2337/diacare.26.6.1790 Gore, 2004, Clinical outcomes measurement: Pain severity in diabetic peripheral neuropathy (DPN) impacts patient functioning, symptom levels of anxiety and depression, and sleep, Journal of Pain, 5, 112, 10.1016/j.jpain.2004.02.416 Gore, 2005, Burden of illness in painful diabetic peripheral neuropathy (DPN): The patients' perspective, Journal of Pain, 6, S28, 10.1016/j.jpain.2005.01.110 Green, 2003, The unequal burden of pain: Confronting racial and ethnic disparities in pain, Pain Medicine, 4, 277, 10.1046/j.1526-4637.2003.03034.x Greene, 1992, Complications: Neuropathy, pathogenetic considerations, Diabetes Care, 15, 1902, 10.2337/diacare.15.12.1902 Haire-Joshu, 2002, Prevention of overweight and obesity in children: Influences on the food environment, Diabetes Educator, 28, 415, 10.1177/014572170202800311 Haythornthwaite, 2000, Psychological aspects of neuropathic pain, Clinical Journal of Pain, 16, S101, 10.1097/00002508-200006001-00017 Hodgson, 1999, Medical care expenditures for diabetes, its chronic complications, and its comorbidities, Preventive Medicine, 29, 173, 10.1006/pmed.1999.0534 Jonsson, 2002, Revealing the cost of Type II diabetes in Europe, Diabetologia, 45, S5, 10.1007/s00125-002-0858-x Kaufman, 2002, Type 2 diabetes mellitus in children and youth: A new epidemic, Journal of Pediatric Endocrinology & Metabolism, 15, 737, 10.1515/JPEM.2002.15.S2.737 King, 1998, Global burden of diabetes, 1995–2025: Prevalence, numerical estimates and projections, Diabetes Care, 21, 1414, 10.2337/diacare.21.9.1414 Krause, 2003, Development of a neuropathic pain questionnaire, Clinical Journal of Pain, 19, 306, 10.1097/00002508-200309000-00004 McDermott, 2005, The burden of neuropathic pain: Results from a cross-sectional survey, European Journal of Pain, 9 1994 Meyer-Rosberg, 2001, Peripheral neuropathic pain—A multidimensional burden for patients, European Journal of Pain, 5, 379, 10.1053/eujp.2001.0259 O'Brien, 1998, Direct medical costs of complications resulting from type 2 diabetes in the U.S., Diabetes Care, 21, 1122, 10.2337/diacare.21.7.1122 Pirart, 1978, Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973, Diabetes Care, 1, 168, 10.2337/diacare.1.3.168 Rosenbloom, 1999, Emerging epidemic of type 2 diabetes in youth, Diabetes Care, 22, 345, 10.2337/diacare.22.2.345 Stewart, 2005, Work related costs of diabetic neuropathic pain in the US: Results from the American Productivity Audit, Journal of Pain, 6, S28, 10.1016/j.jpain.2005.01.107 1990, EuroQol—A new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 Williams, 2002, Assessing the impact of complications on the costs of Type II diabetes, Diabetologia, 45, S13, 10.1007/s00125-002-0859-9 Zelman, 2005, Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy, Pain, 115, 29, 10.1016/j.pain.2005.01.028 Zelman, 2005, Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy, Journal of Pain Symptom Manage, 29, 401, 10.1016/j.jpainsymman.2004.06.018